Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 23.21
(-1.9%)
CNY 23.21
(-1.9%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 346.24 Million CNY | -4.93% |
| 2022 | 364.19 Million CNY | 50.38% |
| 2021 | 242.18 Million CNY | 82.96% |
| 2020 | 132.37 Million CNY | 147.43% |
| 2019 | 53.49 Million CNY | 88.73% |
| 2018 | 28.34 Million CNY | 72.95% |
| 2017 | 16.38 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 375.57 Million CNY | 3.96% |
| 2024 Q1 | 361.45 Million CNY | 4.39% |
| 2024 Q2 | 361.26 Million CNY | -0.05% |
| 2023 Q2 | 418.71 Million CNY | 6.26% |
| 2023 FY | 346.24 Million CNY | -4.93% |
| 2023 Q4 | 346.24 Million CNY | -16.72% |
| 2023 Q3 | 415.74 Million CNY | -0.71% |
| 2023 Q1 | 394.05 Million CNY | 8.2% |
| 2022 Q2 | 692.52 Million CNY | 66.05% |
| 2022 Q1 | 417.05 Million CNY | 72.2% |
| 2022 FY | 364.19 Million CNY | 50.38% |
| 2022 Q4 | 364.19 Million CNY | -45.8% |
| 2022 Q3 | 672.01 Million CNY | -2.96% |
| 2021 FY | 242.18 Million CNY | 82.96% |
| 2021 Q2 | 250.65 Million CNY | 0.0% |
| 2021 Q4 | 242.18 Million CNY | -12.83% |
| 2021 Q3 | 277.83 Million CNY | 10.85% |
| 2021 Q1 | - CNY | -100.0% |
| 2020 FY | 132.37 Million CNY | 147.43% |
| 2020 Q4 | 132.37 Million CNY | 0.0% |
| 2020 Q2 | 131.78 Million CNY | 0.0% |
| 2019 FY | 53.49 Million CNY | 88.73% |
| 2018 FY | 28.34 Million CNY | 72.95% |
| 2017 FY | 16.38 Million CNY | 0.0% |